Boc-D-aspartic acid β-benzyl ester

Boc-D-aspartic acid β-benzyl ester is a D-configured aspartate derivative bearing a Boc-protected α-amino group and a β-benzyl ester at the side chain, making it a protected, stereochemically defined building block for peptide and peptidomimetic synthesis. The combination of an acid-labile N-protecting group and a benzyl-protected side-chain carboxyl enables controlled assembly of aspartate-containing sequences where side-chain functionality must be masked during coupling steps. This protected format is commonly selected in workflows that require reliable condensation chemistry followed by later deprotection to reveal the free carboxylate for downstream coupling or final product formation.

1. Solid-Phase Aspartate Building Block

Boc-D-aspartic acid β-benzyl ester is used by peptide synthesis groups to introduce D-aspartate residues into sequences during solid-phase peptide synthesis, where orthogonal protection and predictable handling are essential for stepwise chain assembly. The Boc-protected α-amino functionality supports routine peptide coupling workflows on resin, while the β-benzyl ester masks the aspartate side-chain carboxyl to prevent undesired side reactions and to maintain chemoselectivity across multiple coupling cycles. This reagent format is particularly relevant for researchers building D-amino-acid-containing peptides for structure-property studies, backbone stereochemistry control, and sequence-specific synthesis where the side-chain carboxyl must be revealed only at a later stage.

2. Solution-Phase Peptide Segment Synthesis

Boc-D-aspartic acid β-benzyl ester is also applied in solution-phase peptide synthesis as a defined protected aspartate building block for preparing peptide segments and coupling fragments that require controlled protection of both the amino terminus and the side-chain carboxyl. The β-benzyl ester provides a stable handle during fragment condensation, helping maintain the integrity of the aspartate side chain while the peptide backbone is assembled in a stepwise manner. Medicinal chemistry and peptidomimetic development teams frequently use this type of protected amino acid to access D-aspartate-containing intermediates that can be carried through iterative synthesis steps before final deprotection and purification.

3. Peptidomimetic and SAR Intermediate Development

Boc-D-aspartic acid β-benzyl ester is frequently employed in pharmaceutical intermediate development and structure-activity relationship (SAR) programs to generate aspartate-containing building blocks that preserve stereochemistry and functional-group protection throughout lead optimization. By keeping the β-carboxyl protected as a benzyl ester during intermediate construction, chemists can focus on assembling the desired scaffold without premature side-chain reactivity interfering with coupling, purification, or downstream transformations. This makes the reagent useful for preparing protected D-aspartate motifs that later serve as inputs for further functionalization, fragment coupling, or conversion to carboxylate-bearing derivatives required for final analog generation.

4. Protected Amino Acid Intermediate for Derivatization

Boc-D-aspartic acid β-benzyl ester serves as a practical protected intermediate when the target is not a final peptide in the immediate step but a protected D-aspartate unit that will be derivatized in subsequent chemistry. The Boc-protected amino group and the β-benzyl ester together provide a controlled protection pattern that supports sequential synthetic planning, including later unveiling of the side-chain carboxylate for additional coupling chemistry or for transformation into other aspartate-derived functional groups. Chemical biology and materials chemistry teams that require defined aspartate stereochemistry in specialized linkers or scaffold fragments often rely on such protected amino acid derivatives to ensure reproducible downstream reactivity.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists